FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 325:599-605 August 29, 1991 Number 9 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

BACKGROUND AND METHODS. Thyroid disease, especially hypothyroidism, is common in patients with Hodgkin's disease who have been treated with irradiation. We reviewed the records of 1787 patients (740 women and 1047 men) with Hodgkin's disease who were treated with radiation therapy alone (810 patients), radiation and chemotherapy (920 patients), or chemotherapy alone (57 patients) at Stanford University between 1961 and 1989. Among these patients, 1533 were alive at the last follow-up, and 254 had died of causes other than Hodgkin's disease. (Four other patients were excluded from the analysis because they had undergone thyroidectomy before treatment for Hodgkin's disease. The thyroid was irradiated in 1677 patients. Follow-up averaged 9.9 years. RESULTS. A total of 573 patients had clinical or biochemical evidence of thyroid disease. Among the 1677 patients whose thyroid was irradiated, the actuarial risk of thyroid disease 20 years after treatment was 52 percent, and it was 67 percent at 26 years. Hypothyroidism was found in 513 patients. A total of 486 patients received thyroxine therapy for elevated serum thyrotropin concentrations and either low free thyroxine (208 patients) or normal free thyroxine values (278 patients); 27 had transient elevations of the serum thyrotropin level that were not treated. Graves' hyperthyroidism developed in 30 patients (2 of whom had not undergone thyroid irradiation), and ophthalmopathy developed in 17 of these patients. Ophthalmopathy developed in four other patients with Graves' disease during a period of hypothyroidism (n = 3) or euthyroidism (n = 1). The risk of Graves' disease was 7.2 to 20.4 times that for normal subjects. Silent thyroiditis with thyrotoxicosis developed in six patients. Forty-four patients were found to have single or multiple thyroid nodules, 26 of whom underwent thyroidectomy. Six of the 44 had papillary or follicular cancers. Among the patients who did not undergo operation, 12 had small functioning nodules, 4 had cysts, and 2 had multinodular goiters. The actuarial risk of thyroid cancer was 1.7 percent. The risk of thyroid cancer was 15.6 times the expected risk. CONCLUSIONS. High risks of thyroid disease persist more than 25 years after patients have received radiation therapy for Hodgkin's disease, reinforcing the need for continued clinical and biochemical evaluation. Prolonged follow-up confirms an elevated risk of thyroid cancer and Graves' disease as well as hypothyroidism in these patients.

Source Information

Department of Radiation Oncology, Stanford University School of Medicine, Calif.

This article has been cited by other articles:

• Schwartz, C. L., Constine, L. S., Villaluna, D., London, W. B., Hutchison, R. E., Sposto, R., Lipshultz, S. E., Turner, C. S., deAlarcon, P. A., Chauvenet, A. (2009). A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood 114: 2051-2059 [Abstract] [Full Text]  
• van Beek, R. D., van den Heuvel-Eibrink, M. M., Hakvoort-Cammel, F. G., van den Bos, C., van der Pal, H. J. H., Krenning, E. P., de Rijke, Y. B., Pieters, R., de Muinck Keizer-Schrama, S. M. P. F. (2009). Bone Mineral Density, Growth, and Thyroid Function in Long-Term Survivors of Pediatric Hodgkin's Lymphoma Treated with Chemotherapy Only. J. Clin. Endocrinol. Metab. 94: 1904-1909 [Abstract] [Full Text]  
• Hudson, M. M., Mulrooney, D. A., Bowers, D. C., Sklar, C. A., Green, D. M., Donaldson, S. S., Oeffinger, K. C., Neglia, J. P., Meadows, A. T., Robison, L. L. (2009). High-Risk Populations Identified in Childhood Cancer Survivor Study Investigations: Implications for Risk-Based Surveillance. JCO 27: 2405-2414 [Abstract] [Full Text]  
• Diller, L., Chow, E. J., Gurney, J. G., Hudson, M. M., Kadin-Lottick, N. S., Kawashima, T. I., Leisenring, W. M., Meacham, L. R., Mertens, A. C., Mulrooney, D. A., Oeffinger, K. C., Packer, R. J., Robison, L. L., Sklar, C. A. (2009). Chronic Disease in the Childhood Cancer Survivor Study Cohort: A Review of Published Findings. JCO 27: 2339-2355 [Full Text]  
• Boehm, B. O, Steinert, M., Dietrich, J. W, Peter, R. U, Belyi, D., Wagemaker, G., Rosinger, S., Fliedner, T. M, Weiss, M. (2009). Thyroid examination in highly radiation-exposed workers after the Chernobyl accident. Eur J Endocrinol 160: 625-630 [Abstract] [Full Text]  
• Diaz, R., Blakey, M. D., Murphy, P. B., Cryar, A. K., Cmelak, A. J. (2009). Thyroid Storm After Intensity-Modulated Radiation Therapy: A Case Report and Discussion. The Oncologist 14: 233-239 [Abstract] [Full Text]  
• Carter, A., Landier, W., Schad, A., Moser, A., Schaible, A., Hanby, C., Kurian, S., Wong, F. L., Villaluna, D., Bhatia, S. (2008). Successful Coordination and Execution of Nontherapeutic Studies in a Cooperative Group Setting: Lessons Learned from Children's Oncology Group Studies. Cancer Epidemiol. Biomarkers Prev. 17: 1665-1673 [Abstract] [Full Text]  
• Biondi, B., Cooper, D. S. (2008). The Clinical Significance of Subclinical Thyroid Dysfunction. Endocr. Rev. 29: 76-131 [Abstract] [Full Text]  
• Mittra, E. S., Niederkohr, R. D., Rodriguez, C., El-Maghraby, T., McDougall, I. R. (2008). Uncommon Causes of Thyrotoxicosis. JNM 49: 265-278 [Abstract] [Full Text]  
• Armstrong, G. T., Sklar, C. A., Hudson, M. M., Robison, L. L. (2007). Long-Term Health Status Among Survivors of Childhood Cancer: Does Sex Matter?. JCO 25: 4477-4489 [Abstract] [Full Text]  
• Dickerman, J. D. (2007). The Late Effects of Childhood Cancer Therapy. Pediatrics 119: 554-568 [Abstract] [Full Text]  
• Boice, J. D. Jr (2007). An Affair of the Heart. JNCI J Natl Cancer Inst 99: 186-187 [Full Text]  
• Metzger, M. L., Hudson, M. M., Somes, G. W., Shorr, R. I., Li, C.-S., Krasin, M. J., Shelso, J., Pui, C.-H., Howard, S. C. (2006). White Race As a Risk Factor for Hypothyroidism After Treatment for Pediatric Hodgkin's Lymphoma. JCO 24: 1516-1521 [Abstract] [Full Text]  
• Ng, A. K., Li, S., Recklitis, C., Neuberg, D., Chakrabarti, S., Silver, B., Diller, L. (2005). A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue. Ann Oncol 16: 1949-1955 [Abstract] [Full Text]  
• Landier, W., Bhatia, S., Eshelman, D. A., Forte, K. J., Sweeney, T., Hester, A. L., Darling, J., Armstrong, F. D., Blatt, J., Constine, L. S., Freeman, C. R., Friedman, D. L., Green, D. M., Marina, N., Meadows, A. T., Neglia, J. P., Oeffinger, K. C., Robison, L. L., Ruccione, K. S., Sklar, C. A., Hudson, M. M. (2004). Development of Risk-Based Guidelines for Pediatric Cancer Survivors: The Children's Oncology Group Long-Term Follow-Up Guidelines From the Children's Oncology Group Late Effects Committee and Nursing Discipline. JCO 22: 4979-4990 [Abstract] [Full Text]  
• Davis, S., Kopecky, K. J., Hamilton, T. E., Onstad, L., and the Hanford Thyroid Disease Study Team, (2004). Thyroid Neoplasia, Autoimmune Thyroiditis, and Hypothyroidism in Persons Exposed to Iodine 131 From the Hanford Nuclear Site. JAMA 292: 2600-2613 [Abstract] [Full Text]  
• Oeffinger, K. C., Hudson, M. M. (2004). Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors. CA Cancer J Clin 54: 208-236 [Abstract] [Full Text]  
• Murray, R. D., Darzy, K. H., Gleeson, H. K., Shalet, S. M. (2002). GH-Deficient Survivors of Childhood Cancer: GH Replacement during Adult Life. J. Clin. Endocrinol. Metab. 87: 129-135 [Abstract] [Full Text]  
• Knobel, H., Loge, J. H., Lund, M. B., Forfang, K./o., Nome, O., Kaasa, S. (2001). Late Medical Complications and Fatigue in Hodgkin's Disease Survivors. JCO 19: 3226-3233 [Abstract] [Full Text]  
• Duhmke, E., Franklin, J., Pfreundschuh, M., Sehlen, S., Willich, N., Ruhl, U., Muller, R.-P., Lukas, P., Atzinger, A., Paulus, U., Lathan, B., Ruffer, U., Sieber, M., Wolf, J., Engert, A., Georgii, A., Staar, S., Herrmann, R., Beykirch, M., Kirchner, H., Emminger, A., Greil, R., Fritsch, E., Koch, P., Drochtert, A., Brosteanu, O., Hasenclever, D., Loeffler, M., Diehl, V. (2001). Low-Dose Radiation Is Sufficient for the Noninvolved Extended-Field Treatment in Favorable Early-Stage Hodgkin's Disease: Long-Term Results of a Randomized Trial of Radiotherapy Alone. JCO 19: 2905-2914 [Abstract] [Full Text]  
• Bryer-Ash, M., Lodhi, W., Robbins, K. T., Morrison, R. (2001). Early Thyrotoxic Thyroiditis After Radiotherapy for Tonsillar Carcinoma. Arch Otolaryngol Head Neck Surg 127: 209-211 [Abstract] [Full Text]  
• Sklar, C., Whitton, J., Mertens, A., Stovall, M., Green, D., Marina, N., Greffe, B., Wolden, S., Robison, L. (2000). Abnormalities of the Thyroid in Survivors of Hodgkin's Disease: Data from the Childhood Cancer Survivor Study. J. Clin. Endocrinol. Metab. 85: 3227-3232 [Abstract] [Full Text]  
• Sinard, R. J., Tobin, E. J., Mazzaferri, E. L., Hodgson, S. E., Young, D. C., Kunz, A. L., Malhotra, P. S., Fritz, M. A., Schuller, D. E. (2000). Hypothyroidism After Treatment for Nonthyroid Head and Neck Cancer. Arch Otolaryngol Head Neck Surg 126: 652-657 [Abstract] [Full Text]  
• Rabes, H. M., Demidchik, E. P., Sidorow, J. D., Lengfelder, E., Beimfohr, C., Hoelzel, D., Klugbauer, S. (2000). Pattern of Radiation-induced RET and NTRK1 Rearrangements in 191 Post-Chernobyl Papillary Thyroid Carcinomas: Biological, Phenotypic, and Clinical Implications. Clin. Cancer Res. 6: 1093-1103 [Abstract] [Full Text]  
• van Leeuwen, F. E., Klokman, W. J., Veer, M. B. v.’t, Hagenbeek, A., Krol, A. D. G., Vetter, U. A. O., Schaapveld, M., van Heerde, P., Burgers, J. M. V., Somers, R., Aleman, B. M. P. (2000). Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood. JCO 18: 487-487 [Abstract] [Full Text]  
• Swerdlow, A. J., Barber, J. A., Hudson, G. V., Cunningham, D., Gupta, R. K., Hancock, B. W., Horwich, A., Lister, T. A., Linch, D. C. (2000). Risk of Second Malignancy After Hodgkin’s Disease in a Collaborative British Cohort: The Relation to Age at Treatment. JCO 18: 498-498 [Abstract] [Full Text]  
• Linch, D. C., Gosden, R. G., Tulandi, T., Tan, S.-L., Hancock, S. L. (2000). Hodgkin's Lymphoma: Choice of Therapy and Late Complications. ASH Education Book 2000: 205-221 [Abstract] [Full Text]  
• Schwartz, C. L. (1999). Long-Term Survivors of Childhood Cancer: The Late Effects of Therapy. The Oncologist 4: 45-54 [Abstract] [Full Text]  
• Aisenberg, A. C. (1999). Problems in Hodgkin's Disease Management. Blood 93: 761-779 [Full Text]  
• Yeung, S.-C. J., Chiu, A. C., Vassilopoulou-Sellin, R., Gagel, R. F. (1998). The Endocrine Effects of Nonhormonal Antineoplastic Therapy. Endocr. Rev. 19: 144-172 [Abstract] [Full Text]  
• Petrone, L. R. (1996). A Primary Care Approach to the Adult Patient With Nodular Thyroid Disease. Arch Fam Med 5: 92-100 [Abstract]  
• Bhatia, S., Ramsay, N. K.C., Bantle, J. P., Mertens, A., Robison, L. L. (1996). Thyroid Abnormalities after Therapy for Hodgkin's Disease in Childhood. The Oncologist 1: 62-67 [Abstract] [Full Text]